Seeking men & women over 18 years old who have recently been diagnosed with acute myeloid leukemia (AML) but are not medically suitable to receive standard chemotherapy.
The main purpose of this study is to investigate the effects the investigational drug has on the patient and their cancer when it is given in combination with another standard drug.
What we're hoping for
Participation in this study may help researchers in gaining knowledge to help other patients with AML in the future.
ClinicalTrials.gov Identifier: NCT03151408